Zobrazeno 1 - 10
of 345
pro vyhledávání: '"Savvidou, I."'
Autor:
Tsekoura, M., Billis, E., Samada, E.K., Savvidou, I., Fousekis, K., Xergia, S., Lampropoulou, S., Tsepis, E.
Publikováno v:
In Foot and Ankle Surgery December 2021 27(8):906-910
Autor:
Lee NT; Australian Centre for Blood Diseases, School of Translational Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia; Monash Biomedical Imaging, Monash University, Clayton, Victoria, Australia., Savvidou I; Australian Centre for Blood Diseases, School of Translational Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia., Selan C; Australian Centre for Blood Diseases, School of Translational Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia., Calvello I; Australian Centre for Blood Diseases, School of Translational Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia., Vuong A; Australian Centre for Blood Diseases, School of Translational Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia., Wright DK; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia., Brkljaca R; Monash Biomedical Imaging, Monash University, Clayton, Victoria, Australia., Willcox A; Australian Centre for Blood Diseases, School of Translational Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia., Chia JSJ; Australian Centre for Blood Diseases, School of Translational Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia., Wang X; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia; Department of Cardiometabolic Health, University of Melbourne, Melbourne, Victoria, Australia; Molecular Imaging and Theranostics Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia., Peter K; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia; Department of Cardiometabolic Health, University of Melbourne, Melbourne, Victoria, Australia., Robson SC; Center for Inflammation Research, Department of Anesthesia, Critical Care & Pain Medicine and Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Medcalf RL; Australian Centre for Blood Diseases, School of Translational Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia., Nandurkar HH; Australian Centre for Blood Diseases, School of Translational Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia., Sashindranath M; Australian Centre for Blood Diseases, School of Translational Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia. Electronic address: maithili.sashindranath@monash.edu.
Publikováno v:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Aug; Vol. 22 (8), pp. 2331-2344. Date of Electronic Publication: 2024 May 14.
Autor:
Georgiou T; Biochemical Genetics Department, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus., Petrou PP; Biochemical Genetics Department, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus., Malekkou A; Biochemical Genetics Department, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus., Ioannou I; Paediatric Neurology Clinic, Archbishop Makarios III Hospital, Nicosia, Cyprus., Gavatha M; Paediatric Neurology Clinic, Archbishop Makarios III Hospital, Nicosia, Cyprus., Skordis N; School of Medicine, University of Nicosia, Nicosia, Cyprus., Nicolaidou P; Basic and Clinical Sciences Department, University of Nicosia Medical School, Nicosia, Cyprus., Savvidou I; Clinical Genetics Department, Archbishop Makarios III Hospital, Nicosia, Cyprus., Athanasiou E; Clinical Genetics Department, Archbishop Makarios III Hospital, Nicosia, Cyprus., Ourani S; Clinical Genetics Department, Archbishop Makarios III Hospital, Nicosia, Cyprus., Papamichael E; Neonatal Intensive Care Unit, Archbishop Makarios III Hospital, Nicosia, Cyprus., Vogazianos M; Centre for Preventive Paediatrics 'Americos Argyriou', Limassol, Cyprus., Dionysiou M; Biochemical Genetics Department, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus., Mavrikiou G; Biochemical Genetics Department, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus., Grafakou O; Clinical Genetics Department, Archbishop Makarios III Hospital, Nicosia, Cyprus.; Inborn Errors of Metabolism Clinic, Archbishop Makarios III Hospital, Nicosia, Cyprus., Tanteles GA; Basic and Clinical Sciences Department, University of Nicosia Medical School, Nicosia, Cyprus.; Clinical Genetics and Genomics Department, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus., Anastasiadou V; Clinical Genetics Department, Archbishop Makarios III Hospital, Nicosia, Cyprus., Drousiotou A; Biochemical Genetics Department, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Publikováno v:
Molecular genetics and metabolism reports [Mol Genet Metab Rep] 2024 Apr 23; Vol. 39, pp. 101083. Date of Electronic Publication: 2024 Apr 23 (Print Publication: 2024).
Autor:
Reale A; Myeloma Research Group, Australian Centre for Blood Diseases, Monash University/Alfred Health, Melbourne, Victoria, Australia.; Central Clinical School, Monash University, Melbourne, Victoria, Australia., Carmichael I; Monash Micro Imaging-AMREP, Monash University, Melbourne, Victoria, Australia., Xu R; Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Nanobiotechnology Laboratory, Australian Centre for Blood Diseases, Monash University/Alfred Health, Melbourne, Victoria, Australia.; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia., Mithraprabhu S; Myeloma Research Group, Australian Centre for Blood Diseases, Monash University/Alfred Health, Melbourne, Victoria, Australia.; Central Clinical School, Monash University, Melbourne, Victoria, Australia., Khong T; Myeloma Research Group, Australian Centre for Blood Diseases, Monash University/Alfred Health, Melbourne, Victoria, Australia.; Central Clinical School, Monash University, Melbourne, Victoria, Australia., Chen M; Myeloma Research Group, Australian Centre for Blood Diseases, Monash University/Alfred Health, Melbourne, Victoria, Australia., Fang H; Molecular Proteomics, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia., Savvidou I; Myeloma Research Group, Australian Centre for Blood Diseases, Monash University/Alfred Health, Melbourne, Victoria, Australia.; Central Clinical School, Monash University, Melbourne, Victoria, Australia., Ramachandran M; Myeloma Research Group, Australian Centre for Blood Diseases, Monash University/Alfred Health, Melbourne, Victoria, Australia.; Central Clinical School, Monash University, Melbourne, Victoria, Australia., Bingham N; Myeloma Research Group, Australian Centre for Blood Diseases, Monash University/Alfred Health, Melbourne, Victoria, Australia.; Central Clinical School, Monash University, Melbourne, Victoria, Australia., Simpson RJ; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia., Greening DW; Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia.; Molecular Proteomics, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia., Spencer A; Myeloma Research Group, Australian Centre for Blood Diseases, Monash University/Alfred Health, Melbourne, Victoria, Australia.; Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, and Department of Clinical Haematology, Monash University, Melbourne, Victoria, Australia.
Publikováno v:
Proteomics [Proteomics] 2021 Jul; Vol. 21 (13-14), pp. e2000119. Date of Electronic Publication: 2021 Mar 05.
Autor:
Savvidou I; Myeloma Research Group, Australian Centre for Blood Diseases, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC 3004, Australia.; Malignant Haematology and Stem Cell Transplantation, Department of Haematology, Alfred Hospital, Melbourne, VIC 3004, Australia., Khong T; Myeloma Research Group, Australian Centre for Blood Diseases, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC 3004, Australia.; Malignant Haematology and Stem Cell Transplantation, Department of Haematology, Alfred Hospital, Melbourne, VIC 3004, Australia., Whish S; Myeloma Research Group, Australian Centre for Blood Diseases, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC 3004, Australia.; Malignant Haematology and Stem Cell Transplantation, Department of Haematology, Alfred Hospital, Melbourne, VIC 3004, Australia., Carmichael I; Monash Micro Imaging-Alfred Research Alliance, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC 3004, Australia., Sepehrizadeh T; Monash Biomedical Imaging, Monash Technology Research Platforms, Monash University, Melbourne, VIC 3004, Australia., Mithraprabhu S; Myeloma Research Group, Australian Centre for Blood Diseases, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC 3004, Australia.; Malignant Haematology and Stem Cell Transplantation, Department of Haematology, Alfred Hospital, Melbourne, VIC 3004, Australia., Horrigan SK; Iterion Therapeutics, 2450 Holcombe Blvd, Houston, TX 77021, USA., de Veer M; Monash Biomedical Imaging, Monash Technology Research Platforms, Monash University, Melbourne, VIC 3004, Australia., Spencer A; Myeloma Research Group, Australian Centre for Blood Diseases, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC 3004, Australia.; Malignant Haematology and Stem Cell Transplantation, Department of Haematology, Alfred Hospital, Melbourne, VIC 3004, Australia.; Department of Clinical Hematology, Monash University, Melbourne, VIC 3004, Australia.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Feb 08; Vol. 14 (3). Date of Electronic Publication: 2022 Feb 08.
Autor:
Mithraprabhu S; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, VIC, Australia. durga.mithraprabhu@monash.edu.; Malignant Hematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, VIC, Australia. durga.mithraprabhu@monash.edu., Chen M; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, VIC, Australia., Savvidou I; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, VIC, Australia.; Malignant Hematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, VIC, Australia., Reale A; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, VIC, Australia.; Malignant Hematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, VIC, Australia., Spencer A; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, VIC, Australia. Andrew.spencer@monash.edu.; Malignant Hematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, VIC, Australia. Andrew.spencer@monash.edu.; Department of Clinical Hematology, Monash University, Clayton, VIC, Australia. Andrew.spencer@monash.edu.
Publikováno v:
Leukemia [Leukemia] 2021 Oct; Vol. 35 (10), pp. 3037.
Autor:
Mithraprabhu S; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia. durga.mithraprabhu@monash.edu.; Malignant Hematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia. durga.mithraprabhu@monash.edu., Chen M; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia., Savvidou I; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia.; Malignant Hematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia., Reale A; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia.; Malignant Hematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia., Spencer A; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia. Andrew.spencer@monash.edu.; Malignant Hematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia. Andrew.spencer@monash.edu.; Department of Clinical Hematology, Monash University, Clayton, Victoria, Australia. Andrew.spencer@monash.edu.
Publikováno v:
Leukemia [Leukemia] 2021 Oct; Vol. 35 (10), pp. 2771-2783. Date of Electronic Publication: 2021 Jul 14.
Autor:
Mithraprabhu S; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia.; Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia., Kalff A; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia.; Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia., Gartlan KH; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Savvidou I; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia.; Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia., Khong T; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia.; Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia., Ramachandran M; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia.; Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia., Cooke RE; Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia.; Haematology Department, Northern Health, Melbourne, Victoria, Australia., Bowen K; Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia., Hill GR; Clinical Research Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington, United States., Reynolds J; Epidemiology and Preventive Medicine, Alfred Health - Monash University, Melbourne, Victoria, Australia., Spencer A; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia.; Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia.; Department of Clinical Haematology, Monash University, Clayton, Victoria, Australia.
Publikováno v:
British journal of haematology [Br J Haematol] 2021 Apr; Vol. 193 (1), pp. 160-170. Date of Electronic Publication: 2020 Sep 18.
Autor:
Xiao, Shumei1 (AUTHOR) xsmncdx2018@163.com, Chen, Lei2 (AUTHOR) lene918@163.com, Chen, Zhichao2 (AUTHOR) chenzhichao@hust.edu.cn, Li, Qiubai1,3 (AUTHOR) qiubaili@hust.edu.cn
Publikováno v:
Pharmaceutics. Nov2024, Vol. 16 Issue 11, p1439. 23p.
Autor:
Reale A; Myeloma Research Group, Australian Centre for Blood Diseases, The Alfred Hospital/Monash University, Melbourne, Australia., Khong T; Myeloma Research Group, Australian Centre for Blood Diseases, The Alfred Hospital/Monash University, Melbourne, Australia., Mithraprabhu S; Myeloma Research Group, Australian Centre for Blood Diseases, The Alfred Hospital/Monash University, Melbourne, Australia., Savvidou I; Myeloma Research Group, Australian Centre for Blood Diseases, The Alfred Hospital/Monash University, Melbourne, Australia., Hocking J; Myeloma Research Group, Australian Centre for Blood Diseases, The Alfred Hospital/Monash University, Melbourne, Australia.; Department of Clinical Haematology, Box Hill, Melbourne, Australia.; Myeloma Clinic, The Alfred Centre, Melbourne, Australia., Bergin K; Myeloma Research Group, Australian Centre for Blood Diseases, The Alfred Hospital/Monash University, Melbourne, Australia., Ramachandran M; Myeloma Research Group, Australian Centre for Blood Diseases, The Alfred Hospital/Monash University, Melbourne, Australia., Chen M; Myeloma Research Group, Australian Centre for Blood Diseases, The Alfred Hospital/Monash University, Melbourne, Australia., Dammacco F; Department of Internal Medicine and Human Oncology, University of Bari 'Aldo Moro', Bari, Italy., Ria R; Department of Internal Medicine and Human Oncology, University of Bari 'Aldo Moro', Bari, Italy., Silvestris F; Department of Internal Medicine and Human Oncology, University of Bari 'Aldo Moro', Bari, Italy., Vacca A; Department of Internal Medicine and Human Oncology, University of Bari 'Aldo Moro', Bari, Italy., Reynolds J; Biostatistics Consulting Platform, Faculty of Medicine, Nursing and Health Sciences, Monash University, The Alfred Centre, Melbourne, Australia., Spencer A; Myeloma Research Group, Australian Centre for Blood Diseases, The Alfred Hospital/Monash University, Melbourne, Australia.; Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia.; Department of Clinical Haematology, Monash University, Melbourne, Australia.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2021 Feb; Vol. 62 (2), pp. 337-347. Date of Electronic Publication: 2020 Oct 31.